Turkey

BioNTech Chief Sahin to Open Cancer Research Center in Turkey

Acclaimed scientist and developer of first coronavirus vaccine, Ugur Sahin has been negotiating with the Turkish government to open up a cancer research center in Turkey, Industry and Technology minister Mustafa Varank revealed on Wednesday.

“He wants to carry out cancer research in Turkey. We have been holding talks to open up a center in Turkey. We would be happy to host Sahin here in Turkey,” said Varank during an interview. Ugur Sahin’s company BioNTech has developed the first coronavirus vaccine that gave hope globally to stem the deadly virus. The company of the Turkish-German scientist has also signed an agreement with Turkey to deliver vaccines.


Turkish Minister Varank said he also offered Sahin to co-produce Turkey’s own local coronavirus vaccine which is at the human trial phase, according to the minister. “”We have three vaccines that are at the human trial phase,” Varank announced.

Ugur Sahin said in December during an interview that Turkish health system was perfect and medical schools in Turkey are very successful. Turkey has managed the coronavirus pandemic well better than European countries whom are implementing mandatory quarantine for international arrivals at the expense of the travelers. Turkey successfully hosted more than 100 thousand repatriated citizens at state-own facilities at the beginning of the pandemic last year government bearing the cost of the operation.

Turkish-German scientist Ugur Sahin and his wife Ozlem Tureci have been hailed by even chancellor Angela Merkel for his early success in coronavirus vaccine studies. Millions of Turks living in Germany have said they hope Sahin’s success would break the racism and discrimination barriers against Turks in Germany.

Print Friendly, PDF & Email

Follow us on Twitter

Languages

Follow us on Twitter

Languages